PT  - JOURNAL ARTICLE
AU  - Vinall, Maria
ED  - Valgimigli, Marco
TI  - Tirofiban Significantly Reduces Myocardial Damage after PCI Compared with Standard Antiplatelet Therapy
DP  - 2008 Nov 01
TA  - MD Conference Express
PG  - 23--24
VI  - 8
IP  - 6
4099  - http://mdc.sagepub.com/content/8/6/23.short
4100  - http://mdc.sagepub.com/content/8/6/23.full
AB  - Results from the 3T/2R study [NCT00398463] demonstrated that the addition of tirofiban to standard therapy decreased the rate of myocardial infarction and resulted in a lower rate of major cardiovascular events 30 days after percutaneous coronary intervention compared with standard antiplatelet therapy alone in poor responders to aspirin or clopidogrel.